Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears
Anavex Life Sciences Corp. (NASDAQ: AVXL) continues advancing its innovative CNS pipeline. Anavex Q1 2026 earnings revealed cash position surging...
Anavex Life Sciences Corp. (NASDAQ: AVXL) continues advancing its innovative CNS pipeline. Anavex Q1 2026 earnings revealed cash position surging...
BD (Becton, Dickinson and Company) (NYSE: BDX) reported first-quarter fiscal 2026 results on February 9, 2026, with revenue of $5.3...
Eli Lilly and Company (NYSE: LLY) on Monday said it signed an agreement to acquire Orna Therapeutics, Inc., a biotechnology...
Medical technology company Becton, Dickinson and Company (NYSE: BDX) reported a decline in adjusted earnings for the first quarter of...
Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year...
Shares of Immunovant Inc (IMVT) Stock trading near the high end of its 52-week range Shares of Immunovant Inc (IMVT)...
Centene Corporation (NYSE: CNC) closed at $39.92, down 2.54% on the day, after reporting fourth-quarter and full-year 2025 results. The...
Encompass Health Corporation (NYSE: EHC) reported its financial results for the fourth quarter and full year ended December 31, 2025,...
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The...
Abbott (NYSE: ABT) on Friday reported positive data from studies evaluating the safety and effectiveness of its Volt Pulsed Field...